中文 | English
Return
Total: 345 , 1/35
Show Home Prev Next End page: GO
Author:(Liang CHU)

1.Immunoregulation of galectins in tumor microenvironment

Zhaohui CHU ; Xiaohua LIANG

Journal of International Oncology 2011;38(11):826-829

2.Logic Problem Analysis on Determination of Syndrome-attribution in A Variety of Animal Model Establishment Methods

Jie CHU ; Maoxin LIANG

World Science and Technology-Modernization of Traditional Chinese Medicine 2013;(7):1665-1669

3.Effects of Ursolic Acid on Cholesterol Metabolism in Hepatic Cells

Kuiying LIANG ; Xia CHU

Herald of Medicine 2017;36(1):9-12

4.Helicobacter pylori and colorectal cancer

Yunjia LIANG ; Yude CHU ; Dejian DAI

Journal of International Oncology 2012;39(3):228-230

6.Simultaneous Determination of Epimedium Glycoside and Other 4 Kinds of Active Ingredients in Xianling Gubao Capsules by Three Wavelength Switching Method

Liang FENG ; Shuhao CHU ; Xiaocai WANG

Chinese Journal of Information on Traditional Chinese Medicine 2017;24(10):68-71

7.Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia to cure advanced ovarian cancer

Xiuju LIANG ; Huili CHU ; Jun WANG ; Jingwang BI

Chinese Journal of Clinical Oncology 2013;(17):1051-1054

8.Expression of serum retinol-binding protein 4 in patients with cholesterol gallstone disease

Jie ZHANG ; Liang CHU ; Lei JIANG ; Qun LIU ; Anhe GUO

Chinese Journal of Postgraduates of Medicine 2012;35(23):29-32

9.Association between polymorphisms in HLA-Ⅱ genes and multiple sclerosis in Guizhou Province

Jin LIANG ; Lan CHU ; Zhu XU ; Liufu ZHANG ; Xin CAO

Chinese Journal of Neurology 2008;41(2):83-86

10.Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway.

Zhaohui CHU ; Xiaohua LIANG ; Xinli ZHOU ; Ruofan HUANG ; Jingwei JIANG

Journal of Integrative Medicine 2011;9(5):533-538

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 345 , 1/35 Show Home Prev Next End page: GO